Recent advances in targeted therapy for glioblastoma

作者: Shivani Mittal , Shrikant Pradhan , Tapasya Srivastava

DOI: 10.1586/14737175.2015.1061934

关键词: Brain tumorOncologyTargeted therapyClinical trialRegimenDrug developmentTemozolomideMedicineInternal medicineRadiation therapyStandard treatmentPharmacology

摘要: … Of all the known tumors, GBM is the most challenging because of its infiltrating nature, recurrence tendencies and resistance to chemotherapy. Its treatment continues to remain …

参考文章(91)
Eric T. Wong, Kenneth R. Hess, Mary Jo Gleason, Kurt A. Jaeckle, Athanassios P. Kyritsis, Michael D. Prados, Victor A. Levin, W.K. Alfred Yung, Outcomes and Prognostic Factors in Recurrent Glioma Patients Enrolled Onto Phase II Clinical Trials Journal of Clinical Oncology. ,vol. 17, pp. 2572- 2578 ,(1999) , 10.1200/JCO.1999.17.8.2572
Mine Erguven, Nuray Yazihan, Esin Aktas, Akin Sabanci, Chiang J Li, Gulperi Oktem, Ayhan Bilir, None, Carvedilol in glioma treatment alone and with imatinib in vitro International Journal of Oncology. ,vol. 36, pp. 857- 866 ,(2010) , 10.3892/IJO_00000563
Lin Cheng, Shideng Bao, Jeremy N. Rich, Potential therapeutic implications of cancer stem cells in glioblastoma Biochemical Pharmacology. ,vol. 80, pp. 654- 665 ,(2010) , 10.1016/J.BCP.2010.04.035
Krishna Reddy, Denise Damek, Laurie E. Gaspar, Douglas Ney, Allen Waziri, Kevin Lillehei, Kelly Stuhr, Brian D. Kavanagh, Changhu Chen, Phase II Trial of Hypofractionated IMRT With Temozolomide for Patients With Newly Diagnosed Glioblastoma Multiforme International Journal of Radiation Oncology Biology Physics. ,vol. 84, pp. 655- 660 ,(2012) , 10.1016/J.IJROBP.2012.01.035
David A. Nathanson, Beatrice Gini, Jack Mottahedeh, Koppany Visnyei, Tomoyuki Koga, German Gomez, Ascia Eskin, Kiwook Hwang, Jun Wang, Kenta Masui, Andres Paucar, Huijun Yang, Minori Ohashi, Shaojun Zhu, Jill Wykosky, Rachel Reed, Stanley F. Nelson, Timothy F. Cloughesy, C. David James, P. Nagesh Rao, Harley I. Kornblum, James R. Heath, Webster K. Cavenee, Frank B. Furnari, Paul S. Mischel, Targeted therapy resistance mediated by dynamic regulation of extrachromosomal mutant EGFR DNA. Science. ,vol. 343, pp. 72- 76 ,(2014) , 10.1126/SCIENCE.1241328
Giuseppe Minniti, Gaetano Lanzetta, Claudia Scaringi, Paola Caporello, Maurizio Salvati, Antonella Arcella, Vitaliana De Sanctis, Felice Giangaspero, Riccardo Maurizi Enrici, Phase II study of short-course radiotherapy plus concomitant and adjuvant temozolomide in elderly patients with glioblastoma. International Journal of Radiation Oncology Biology Physics. ,vol. 83, pp. 93- 99 ,(2012) , 10.1016/J.IJROBP.2011.06.1992
Balveen Kaur, Fatima W. Khwaja, Eric A. Severson, Shannon L. Matheny, Daniel J. Brat, Erwin G. Van Meir, Hypoxia and the hypoxia-inducible-factor pathway in glioma growth and angiogenesis Neuro-oncology. ,vol. 7, pp. 134- 153 ,(2005) , 10.1215/S1152851704001115
Maria Teresa Solomón, Julio César Selva, Javier Figueredo, José Vaquer, Carolina Toledo, Nelson Quintanal, Silvia Salva, Rafael Domíngez, José Alert, Jorge Juan Marinello, Mauricio Catalá, Martha González Griego, Juan Antonio Martell, Patricia Lorenzo Luaces, Javier Ballesteros, Niurys de-Castro, Ferdinand Bach, Tania Crombet, Radiotherapy plus nimotuzumab or placebo in the treatment of high grade glioma patients: results from a randomized, double blind trial BMC Cancer. ,vol. 13, pp. 299- 299 ,(2013) , 10.1186/1471-2407-13-299
Florence Lefranc, Tatjana Mijatovic, Yasuko Kondo, Sébastien Sauvage, Isabelle Roland, Olivier Debeir, Danijela Krstic, Vesna Vasic, Philippe Gailly, Seiji Kondo, Gustavo Blanco, Robert Kiss, Targeting the alpha 1 subunit of the sodium pump to combat glioblastoma cells. Neurosurgery. ,vol. 62, pp. 211- 222 ,(2008) , 10.1227/01.NEU.0000311080.43024.0E
Napoleone Ferrara, Hans-Peter Gerber, Jennifer LeCouter, None, The biology of VEGF and its receptors. Nature Medicine. ,vol. 9, pp. 669- 676 ,(2003) , 10.1038/NM0603-669